SCCORE AI TECH DIAGNOSTIC LIMITED
SCCORE AI TECH DIAGNOSTIC LIMITED develops and manufactures AI-powered autonomous health screening kiosks (Medigo, Kidigo, Femigo) that capture 75+ clinical parameters in 10 minutes, selling via CapEx and subscription to enterprises, schools, governments, and healthcare distributors globally.
- Company typePrivate
- Founded2026
- Headquarters—
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What SCCORE AI TECH DIAGNOSTIC LIMITED does
SCCORE AI TECH DIAGNOSTIC LIMITED is a privately held healthcare technology company that develops and manufactures AI-powered autonomous health screening kiosks for preventive diagnostics. The company operates a dual-hub model with indigenous hardware manufacturing in Ras Al Khaimah, UAE and a dedicated AI research and software engineering hub in Limassol, Cyprus, enabling full in-house control over both the physical terminal stack and the proprietary deep-learning models that drive screening. Its three product lines — Medigo (general adult screening, 75+ clinical parameters in 10 minutes), Kidigo (pediatric screening, 100+ assessments with AI autism and developmental screening), and Femigo (women's and maternal health screening) — are designed for deployment in schools, corporate hubs, government health programs, healthcare distributors, and remote or underserved communities.
The underlying technology combines clinical-grade certified sensors (6-lead ECG, digital spirometry, digital auscultation, vision, skin, oral, MUAC) with proprietary machine-learning models that process multimodal diagnostic data locally at the edge, eliminating reliance on third-party or white-label platforms. The platform is offline-capable with battery backup and syncs to a HIPAA-compliant cloud, enabling deployment in low-connectivity settings, and routes outputs via WhatsApp/SMS reports and secure APIs into enterprise dashboards and Hospital Management Systems.
The business model is hybrid: one-time hardware sales (CapEx) plus recurring AI analytics and telemedicine subscription (Opex), supported by direct enterprise field sales and a four-track channel partner program (Distribution, Government, Enterprise, Education). The company is certified to ISO 13485, CE Mark, USFDA, and HIPAA standards, and is led by founders Ravindra Raul (CEO) and Dr. Ankit Desai (COO) alongside a chairman and honorary chairman with global public-health credentials. No external institutional funding rounds have been disclosed.
SCCORE AI TECH DIAGNOSTIC LIMITED firmographics
Firmographics- Name
- SCCORE AI TECH DIAGNOSTIC LIMITED
- Legal name
- Sccore AI Tech Diagnostic LTD
- Website
- https://sccoreaitech.com
- Company type
- Private
- Founded year
- 2026
- Operating status
- Operating
- Short description
- SCCORE AI TECH DIAGNOSTIC LIMITED develops and manufactures AI-powered autonomous health screening kiosks (Medigo, Kidigo, Femigo) that capture 75+ clinical parameters in 10 minutes, selling via CapEx and subscription to enterprises, schools, governments, and healthcare distributors globally.
- Ownership category
- akta.pro rank
SCCORE AI TECH DIAGNOSTIC LIMITED industry classification
Industry- Product category
- AI Healthcare Robotics
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
- akta.pro secondary industry
- Medical Imaging AI (HDAAAEAH)
Keywords
SCCORE AI TECH DIAGNOSTIC LIMITED business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Autonomous Health Screening Kiosk Sales: Sale of hardware platforms (Medigo, Kidigo, Femigo) to enterprise, institutional, and government clients. CapEx model with allocation and termination policies per master enterprise service agreements.
- AI Analytics & Telemedicine Services: Ongoing AI-driven diagnostic analysis, smart health reports delivered via SMS/WhatsApp, and telemedicine consultation services. Subscription or per-use model.
- Healthcare Partnership & Distribution: Revenue from deploying screening infrastructure through healthcare innovation partnerships, distributors, and operators in global sectors.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Enterprise / Institutional Purchase (Capex) |
| Subscription | Annual | Rental / Operational Model (Opex) |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
SCCORE AI TECH DIAGNOSTIC LIMITED product offering
Product offeringCore offering
SCCORE AI Tech designs, manufactures, and sells AI-powered autonomous health screening kiosks and robots for preventive diagnostics. Its three core hardware products — Medigo (general adult screening, 75+ parameters in 10 minutes), Kidigo (pediatric screening, 100+ pediatric assessments with AI autism screening), and Femigo (women's health screening) — combine clinical-grade certified sensors with proprietary deep-learning AI models developed in Cyprus. The company sells and rents these platforms to enterprises, schools, government agencies, and healthcare distributors globally, complemented by ongoing AI analytics, telemedicine, and digital health report subscription services.
Product overview
SCCORE AI Tech delivers an integrated AI Healthcare Robotics ecosystem for preventive screening through three distinct product lines: Medigo (adult health screening kiosk with 75+ tests), Kidigo (pediatric screening robot with 100+ assessments), and Femigo (women's health infrastructure). The platform combines autonomous health kiosks with proprietary AI models developed in Cyprus and hardware manufactured in the UAE, enabling continuous, population-scale preventive healthcare screening.
Differentiator
Problem solved
Functional benefit
Brands
- Medigo: AI-powered health screening kiosk delivering 75+ health assessments in under 10 minutes for general population preventive healthcare.
- Kidigo
- Femigo
Products and services
- Medigo AI-powered autonomous health screening kiosk delivering 75+ clinical health assessments, intelligent health insights, and instant digital reports in under 10 minutes; designed for preventive healthcare screening at scale in corporate hubs, public spaces, and healthcare facilities.
- Kidigo Child-friendly AI robotic wellness companion for schools, clinics, and early childhood institutions delivering 100+ pediatric assessments including AI autism screening, gamified interaction, built-in telemedicine, and longitudinal WHO growth chart tracking.
- Femigo Privacy-first women's health screening layer for clinics, institutions, and maternal health programs, engineered for dignified, clinical-grade maternal health screening at scale.
- AI Analytics and Telemedicine Services Ongoing AI-driven diagnostic analysis, smart health reports delivered via SMS/WhatsApp, and telemedicine consultation services provided on a subscription or per-use basis alongside the company's screening kiosk deployments.
Quantifiable outcome
- 95% screening accuracy with clinical-grade sensors
- +3 more outcomes
Companies that use SCCORE AI TECH DIAGNOSTIC LIMITED
Customer profileSegments6 records
Ideal customer profiles5 records
SCCORE AI TECH DIAGNOSTIC LIMITED technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability8 records
Feature7 records
SCCORE AI TECH DIAGNOSTIC LIMITED partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Healthcare Innovation Partnership EcosystemcoreFull zero-dependency screening infrastructure partnerships providing 75+ certified clinical parameters, robust offline edge computing, and heavy-duty battery backups for uninterrupted operational reliability anywhere in the world. Integration with existing corporate environments, school networks, and public health systems.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
SCCORE AI TECH DIAGNOSTIC LIMITED competitors and assessment
Company assessmentEmerging players
- Ada Health: Ada Health provides an AI symptom assessment and care navigation platform used by health systems, insurers, and employers. Comparable AI health assessment positioning and enterprise/government GTM, but app-first rather than hardware-screening model.
- Biofourmis: Biofourmis delivers AI-based remote patient monitoring and predictive analytics for hospitals and pharmaceutical clients. Comparable AI-driven continuous health monitoring model, though primarily software/cloud rather than physical screening kiosks.
Direct peers
- Withings: Withings produces connected health devices (BPM Core, Body Scan, ScanWatch) for vitals, ECG, and body composition screening with companion apps and health platforms. Comparable connected health screening device portfolio targeting consumer and enterprise wellness.
- Forward Health: Forward (formerly Forward Health) operates AI-powered preventive care clinics and health kiosks (CarePods) for continuous biometric monitoring and screening. Most direct competitor to Sccore AI Tech's autonomous health screening kiosks targeting enterprise and consumer preventive care.
- AliveCor: AliveCor (KardiaMobile) makes AI-driven ECG/ECG screening devices that deliver clinical-grade cardiac diagnostics for consumers and enterprises. Comparable AI cardiac screening (6-lead ECG) capability as Sccore's Medigo platform.
- Eko Health: Eko Health builds AI-powered digital stethoscopes and cardiac screening devices with FDA-cleared algorithms for heart and lung auscultation. Directly overlaps with Sccore's digital auscultation, ECG, and pulmonary function screening features.
- TytoCare: TytoCare provides connected remote diagnostic devices that enable comprehensive telehealth examinations including heart, lung, skin, and throat from any location. Directly comparable to Sccore's remote autonomous screening model with AI-assisted diagnostics and edge capture.
- Butterfly Network: Butterfly Network manufactures AI-powered handheld ultrasound devices with cloud and edge processing for point-of-care imaging across clinical and remote settings. Comparable AI-enabled portable diagnostic hardware with edge inference for medical imaging.
Broad incumbents
- Tempus: Tempus applies AI to clinical and molecular data for diagnostics and precision medicine, serving health systems, life sciences, and patients. Broad AI-diagnostics incumbent with overlapping enterprise healthcare buyer base, though focused on data-driven rather than physical screening.
- Babylon Health: Babylon Health (now eMed) provides AI-driven health assessment, virtual care, and population health platforms to enterprises and governments globally. Broad incumbent in AI healthcare with overlapping enterprise/government distribution motion but different delivery (virtual-first vs. hardware kiosks).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
SCCORE AI TECH DIAGNOSTIC LIMITED social profiles
Digital presenceSCCORE AI TECH DIAGNOSTIC LIMITED compliance and trust
Trust signalCompliance4 records
SCCORE AI TECH DIAGNOSTIC LIMITED financial estimates
Financial estimateRevenue estimate
Valuation estimate
SCCORE AI TECH DIAGNOSTIC LIMITED leadership team
Management profileNumber of profiles
Profiles9 records
SCCORE AI TECH DIAGNOSTIC LIMITED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SCCORE AI TECH DIAGNOSTIC LIMITED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SCCORE AI TECH DIAGNOSTIC LIMITED
What does SCCORE AI TECH DIAGNOSTIC LIMITED do?
SCCORE AI Tech designs, manufactures, and sells AI-powered autonomous health screening kiosks and robots for preventive diagnostics. Its three core hardware products — Medigo (general adult screening, 75+ parameters in 10 minutes), Kidigo (pediatric screening, 100+ pediatric assessments with AI autism screening), and Femigo (women's health screening) — combine clinical-grade certified sensors with proprietary deep-learning AI models developed in Cyprus. The company sells and rents these platforms to enterprises, schools, government agencies, and healthcare distributors globally, complemented by ongoing AI analytics, telemedicine, and digital health report subscription services.
Is SCCORE AI TECH DIAGNOSTIC LIMITED a public or private company?
SCCORE AI TECH DIAGNOSTIC LIMITED is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SCCORE AI TECH DIAGNOSTIC LIMITED founded?
SCCORE AI TECH DIAGNOSTIC LIMITED was founded in 2026.
How does SCCORE AI TECH DIAGNOSTIC LIMITED make money?
Three revenue lines are on record. Autonomous Health Screening Kiosk Sales are the primary driver. The others are AI Analytics & Telemedicine Services and healthcare Partnership & Distribution.
Who are SCCORE AI TECH DIAGNOSTIC LIMITED's main competitors?
Emerging players on record are Ada Health and Biofourmis. Direct peers are Withings, Forward Health, AliveCor, Eko Health, TytoCare and Butterfly Network. Broad incumbents are Tempus and Babylon Health.
Does SCCORE AI TECH DIAGNOSTIC LIMITED have an API?
No public API is recorded for SCCORE AI TECH DIAGNOSTIC LIMITED.
What industry is SCCORE AI TECH DIAGNOSTIC LIMITED in?
SCCORE AI TECH DIAGNOSTIC LIMITED's product category is AI Healthcare Robotics. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 33451 and its SIC code is 3841.